NCT04157985 2025-12-11Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsUniversity of PittsburghPhase 3 Completed161 enrolled
NCT03126110 2025-08-14Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Completed145 enrolled 47 charts
NCT03599713 2025-08-05A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma (POD1UM-201)Incyte CorporationPhase 2 Completed107 enrolled 16 charts 1 FDA
NCT04242199 2025-07-14Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Completed182 enrolled